This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEWTOWN, Pa., Nov. 27, 2013 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Ramesh Kumar, Ph.D., President and CEO, will present at the 25
th Annual Piper Jaffray Healthcare Conference in New York, NY. The presentation will take place on Wednesday, December 4
th at 3:30 p.m. ET.
A live webcast will be available at
this link or can be accessed by visiting "Events & Presentations" in the Investors and Media section of the Company's website at
www.onconova.com . An archived replay of the webcast will be available on the Company's website for 90 days after the conference.
About Onconova Therapeutics, Inc.
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and pre-clinical stage drug development candidates are derived from its extensive chemical library and are designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. In addition to rigosertib, the Company's most advanced product candidate, two other candidates are in clinical trials, and several candidates are in pre-clinical stages. For more information, please visit
CONTACT: Onconova Therapeutics
Benjamin Hoffman, 267-759-3680
MacDougall Biomedical Communications
Chris Erdman, 781-235-3060